 |
 |
It makes you wonder Two nueros' have told me that selegilene works in only 10-15% of all parkinsons patients therefore since it only works for a limited number of parkies one might ponder that since it isn't that effective that it probably doesn't increase any rate either positively or negatively on the grand scale of things. If this is true then and I have no reason to question nueros' statements other than by my personal experience and they are probably speaking from both their experiences of medical information and from the indidvidual patients they have worked with it makes u really wonder how many are on this drug and kept on this drug that does not help the indivdual at all and continue to be on it under some perceived medical or physcological benefit? I guess the good thing it keeps 15% of the parkies who receive a benefit healthy for longer priod of time and helps the drug companies maintian an 85% healthy profit the rest of the time. Don 52/4 PD+ > > Selegiline has been used as a treatment for Parkinson's for nearly 25 > years, but excitement about the drug peaked in the mid-1980s when > research suggested that it may have neuroprotective effects, thereby > slowing the effects of the disease on the brain. But a later study raised > doubts about that theory. > > "The debate has been whether selegiline actually affects the > progression of the disease or whether it just affects the symptoms," > Langston said. "While proving that selegiline -- or any anti-parkinsonian > drug -- is neuroprotective remains beyond our technical grasp, this > study shows us that at the very least treating patients with selegiline > and levodopa is not a bad thing, and in fact may be a very good thing."